What is Pinehurst Dermatology?
Pinehurst Dermatology & Mohs Surgery Center operates as a specialized healthcare provider, focusing on the intersection of medical dermatology, advanced skin cancer diagnostics, and precision Mohs surgery. The practice distinguishes itself through a comprehensive care model that addresses complex skin, hair, and nail pathologies. Beyond its clinical surgical capabilities, the company maintains a strategic retail presence through the distribution of medical-grade skincare products, effectively bridging the gap between clinical intervention and long-term dermatological maintenance. This dual-revenue approach, combined with a commitment to high-precision patient outcomes, establishes the firm as a critical player in regional dermatological health services.
How much funding has Pinehurst Dermatology raised?
Pinehurst Dermatology has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Pinehurst Dermatology
PPP
Public-Private Partnership
What's next for Pinehurst Dermatology?
With the recent infusion of capital, Pinehurst Dermatology is poised to enter a phase of strategic expansion and infrastructure optimization. The late-stage nature of this funding suggests a focus on scaling clinical capacity, potentially through the acquisition of advanced diagnostic technologies or the expansion of its surgical facilities to meet rising demand for skin cancer treatments. Furthermore, the firm is likely to prioritize the integration of digital health solutions to streamline patient intake and follow-up care, ensuring that the quality of service remains consistent as the practice grows. By reinforcing its market position, Pinehurst Dermatology aims to solidify its reputation as a leader in specialized skin health, leveraging its recent financial backing to drive long-term operational efficiency and clinical excellence.
See full Pinehurst Dermatology company page
